BTTC11-01: Randomized, Double-Blind, Placebo-Controlled Trial of Lacosamide for Seizure Prophylaxis in Patients With High-Grade Gliomas

7322-CTO
Cancer - Brain
  1. Patients must be 18 years or older.
  2. Patients with histologically confirmed supratentorial high-grade glioma will be eligible for this protocol.
  3. All patients must sign an informed consent indicating that they are aware of the investigational nature of this study.

Please contact us for full eligibility criteria.

Open
Tiffany Pearce